Karen Prange Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen Prange.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen Prange. Karen Prange is SVP&Pres, Uro & Pelvic Health in BOSTON SCIENTIFIC CORP ($BSX) and SVP&Pres, Uro & Women's Health in BOSTON SCIENTIFIC CORP ($BSX) and Director in CANTEL MEDICAL CORP ($CMN) and EVP&CEO Gl.AH.Med.Den.Sur.Grp in HENRY SCHEIN INC ($HSIC) and Director in AtriCure, Inc. ($ATRC) and Director in NEVRO CORP ($NVRO).
Latest Insider Trading Transactions of Karen Prange
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRC, BSX, CMN, HSIC, NVRO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2021 | ATRC | AtriCure, Inc. | Prange Karen | Director | Grant | A | 0.00 | 1,749 | 0 | 10,103 | 8.4 K to 10.1 K (+20.94 %) |
| May 24 2021 | ATRC | AtriCure, Inc. | Prange Karen | Director | Grant | A | 0.00 | 1,749 | 0 | 10,103 | 8.4 K to 10.1 K (+20.94 %) |
| Jul 31 2020 | CMN | CANTEL MEDICAL COR ... | Prange Karen | Director | Grant | A | 0.00 | 1,935 | 0 | 1,935 | 0 to 1.9 K |
| May 22 2020 | ATRC | AtriCure, Inc. | Prange Karen | Director | Grant | A | 0.00 | 2,452 | 0 | 8,354 | 5.9 K to 8.4 K (+41.55 %) |
| Dec 18 2019 | NVRO | NEVRO CORP | Prange Karen | Director | Grant | A | 0.00 | 2,703 | 0 | 2,703 | 0 to 2.7 K |
| Dec 05 2019 | ATRC | AtriCure, Inc. | Prange Karen | Director | Grant | A | 0.00 | 5,902 | 0 | 5,902 | 0 to 5.9 K |
| Mar 06 2018 | HSIC | HENRY SCHEIN INC | Prange Karen | EVP&CEO Gl.AH.Med.D ... | Grant | A | 0.00 | 19,558 | 0 | 62,902 | 43.3 K to 62.9 K (+45.12 %) |
| Mar 08 2017 | HSIC | HENRY SCHEIN INC | Prange Karen | EVP&CEO Gl.AH.Med.D ... | Grant | A | 0.00 | 8,777 | 0 | 21,672 | 12.9 K to 21.7 K (+68.07 %) |
| Jun 14 2016 | HSIC | HENRY SCHEIN INC | Prange Karen | EVP&CEO Gl.AH.Med.D ... | Grant | A | 0.00 | 12,895 | 0 | 12,895 | 0 to 12.9 K |
| Mar 08 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Sell | S | 17.27 | 14,747 | 254,749 | 38,395 | 53.1 K to 38.4 K (-27.75 %) |
| Mar 01 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Option Exercise | M | 0.00 | 3,721 | 0 | 7,443 | |
| Mar 01 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Payment of Exercise | F | 17.21 | 1,753 | 30,169 | 53,142 | 54.9 K to 53.1 K (-3.19 %) |
| Mar 01 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Buy | M | 0.00 | 3,721 | 0 | 54,895 | 51.2 K to 54.9 K (+7.27 %) |
| Feb 26 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Option Exercise | M | 0.00 | 2,102 | 0 | 6,308 | |
| Feb 26 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Payment of Exercise | F | 17.33 | 991 | 17,174 | 51,174 | 52.2 K to 51.2 K (-1.90 %) |
| Feb 26 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Buy | M | 0.00 | 2,102 | 0 | 52,165 | 50.1 K to 52.2 K (+4.20 %) |
| Feb 25 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Option Exercise | M | 0.00 | 2,299 | 0 | 9,197 | |
| Feb 25 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Payment of Exercise | F | 17.24 | 1,001 | 17,257 | 50,063 | 51.1 K to 50.1 K (-1.96 %) |
| Feb 25 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Buy | M | 0.00 | 2,299 | 0 | 51,064 | 48.8 K to 51.1 K (+4.71 %) |
| Feb 24 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Option Exercise | A | 17.26 | 33,726 | 582,111 | 33,726 | |
| Feb 24 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Option Exercise | A | 0.00 | 12,508 | 0 | 12,508 | |
| Feb 24 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Option Exercise | A | 0.00 | 11,587 | 0 | 11,587 | |
| Feb 24 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Payment of Exercise | F | 17.26 | 12,094 | 208,742 | 48,765 | 60.9 K to 48.8 K (-19.87 %) |
| Feb 24 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Grant | A | 0.00 | 37,212 | 0 | 60,859 | 23.6 K to 60.9 K (+157.36 %) |
| Feb 09 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Sell | S | 16.05 | 6,216 | 99,785 | 23,647 | 29.9 K to 23.6 K (-20.82 %) |
| Jan 05 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Option Exercise | M | 0.00 | 18,866 | 0 | 0 | |
| Jan 05 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Payment of Exercise | F | 18.44 | 6,433 | 118,625 | 29,863 | 36.3 K to 29.9 K (-17.72 %) |
| Jan 05 2016 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Pel ... | Buy | M | 0.00 | 18,866 | 0 | 36,296 | 17.4 K to 36.3 K (+108.24 %) |
| Jul 07 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Sell | S | 17.66 | 17,456 | 308,308 | 17,430 | 34.9 K to 17.4 K (-50.04 %) |
| Jul 06 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | M | 0.00 | 25,862 | 0 | 51,724 | |
| Jul 06 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Payment of Exercise | F | 17.57 | 8,406 | 147,693 | 34,886 | 43.3 K to 34.9 K (-19.42 %) |
| Jul 06 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Buy | M | 0.00 | 25,862 | 0 | 43,292 | 17.4 K to 43.3 K (+148.38 %) |
| Mar 04 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Sell | S | 16.79 | 2,492 | 41,838 | 17,430 | 19.9 K to 17.4 K (-12.51 %) |
| Mar 03 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | M | 0.00 | 3,721 | 0 | 11,164 | |
| Mar 03 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Payment of Exercise | F | 16.90 | 1,229 | 20,770 | 19,922 | 21.2 K to 19.9 K (-5.81 %) |
| Mar 03 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Buy | M | 0.00 | 3,721 | 0 | 21,151 | 17.4 K to 21.2 K (+21.35 %) |
| Feb 25 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | A | 16.31 | 32,327 | 527,253 | 32,327 | |
| Feb 25 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | A | 0.00 | 10,701 | 0 | 10,701 | |
| Feb 25 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | A | 0.00 | 11,496 | 0 | 11,496 | |
| Mar 02 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Sell | S | 16.80 | 1,307 | 21,963 | 17,430 | 18.7 K to 17.4 K (-6.98 %) |
| Feb 26 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | M | 0.00 | 2,102 | 0 | 8,410 | |
| Feb 26 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Payment of Exercise | F | 16.62 | 795 | 13,213 | 18,737 | 19.5 K to 18.7 K (-4.07 %) |
| Feb 26 2015 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Buy | M | 0.00 | 2,102 | 0 | 19,532 | 17.4 K to 19.5 K (+12.06 %) |
| Mar 04 2014 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | M | 0.00 | 3,721 | 0 | 14,885 | |
| Mar 04 2014 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Payment of Exercise | F | 13.10 | 1,411 | 18,484 | 19,740 | 21.2 K to 19.7 K (-6.67 %) |
| Mar 04 2014 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Buy | M | 0.00 | 3,721 | 0 | 21,151 | 17.4 K to 21.2 K (+21.35 %) |
| Feb 26 2014 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | A | 13.08 | 25,045 | 327,589 | 25,045 | |
| Feb 26 2014 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | A | 0.00 | 18,866 | 0 | 18,866 | |
| Feb 26 2014 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | A | 0.00 | 10,512 | 0 | 10,512 | |
| Jul 03 2013 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | M | 0.00 | 25,862 | 0 | 103,448 | |
| Jul 03 2013 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Payment of Exercise | F | 9.17 | 8,432 | 77,321 | 17,430 | 25.9 K to 17.4 K (-32.60 %) |
| Jul 03 2013 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Buy | M | 0.00 | 25,862 | 0 | 25,862 | 0 to 25.9 K |
| Mar 04 2013 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | A | 7.39 | 48,439 | 357,964 | 48,439 | |
| Mar 04 2013 | BSX | BOSTON SCIENTIFIC ... | Prange Karen | SVP&Pres, Uro & Wom ... | Option Exercise | A | 0.00 | 18,606 | 0 | 18,606 |
Page: 1